Protective effects of anti‐C5a peptide antibodies in experimental sepsis
Open Access
- 19 January 2001
- journal article
- fj express-summary
- Published by Wiley in The FASEB Journal
- Vol. 15 (3), 568-570
- https://doi.org/10.1096/fj.00-0653fje
Abstract
We evaluated antibodies to different peptide regions of rat C5a in the sepsis model of cecal ligation and puncture (CLP) for their protective effects in rats. Rabbit polyclonal antibodies were developed to the following peptide regions of rat C5a: amino-terminal region (A), residues 1-16; middle region (M), residues 17-36; and the carboxyl-terminal region (C), residues 58-77. With rat neutrophils, the chemotactic activity of rat C5a was significantly inhibited by antibodies with the following rank order: anti-C > anti-M ≫ anti-A. In vivo, antibodies to the M and C (but not A) regions of C5a were protective in experimental sepsis, as determined by survival over a 10-day period, in a dose-dependent manner. The relative protective efficacies of anti-C5a preparations (in descending order of efficacy) were anti-C ≥ anti-M ≫ anti-A. In CLP rats, a delay in infusion of antibodies, which were injected at 6 or 12 h after CLP, still resulted in significant improvement in survival rates. These in vivo and in vitro data suggest that there are optimal targets on C5a for blockade during sepsis and that delayed infusion of anti-C5a antibody until after onset of clinical evidence of sepsis still provides protective effects.Keywords
Funding Information
- National Institutes of Health (GM‐29507, GM‐31963)
This publication has 32 references indexed in Scilit:
- Effects of anti‐C5a monoclonal antibodies on oxygen use in a porcine model of severe sgifisEuropean Journal of Clinical Investigation, 1998
- Inhibition of interleukin‐6 synthesis in an animal model of septic shock by anti‐C5a monoclonal antibodiesEuropean Journal of Immunology, 1996
- Site‐specific mutagenesis of residues in the human C5a anaphylatoxin which are involved in possible interaction with the C5a receptorJBIC Journal of Biological Inorganic Chemistry, 1994
- P-selectin and platelet-activating factor mediate initial endotoxin-induced neutropenia.The Journal of Experimental Medicine, 1994
- Complement activation and the prognostic value of C3a in patients at risk of adult respiratory distress syndromeClinical and Experimental Immunology, 1990
- Tertiary structure of human complement component C5a in solution from nuclear magnetic resonance dataBiochemistry, 1989
- The Effect of Trauma on Serum C3 Activation and its Correlation with Injury Severity Score in ManThe Journal of Trauma and Acute Care Surgery, 1986
- The Role of C5 in Septic Lung InjuryAnnals of Surgery, 1985
- Primate erythrocyte-immune complex-clearing mechanism.JCI Insight, 1983
- Profile of Complement Components in Patients with Severe BurnsThe Journal of Trauma and Acute Care Surgery, 1980